• SPX
  • $5,948.71
  • 0.53 %
  • $31.60
  • DJI
  • $43,870.35
  • 1.06 %
  • $461.88
  • N225
  • $38,026.17
  • -0.85 %
  • -$326.17
  • FTSE
  • $8,149.27
  • 0.79 %
  • $64.20
  • IXIC
  • $18,972.42
  • 0.03 %
  • $6.28
Pacira BioSciences, Inc. (PCRX) Stock Price, News & Analysis

Pacira BioSciences, Inc. (PCRX) Stock Price, News & Analysis

Currency in USD Disclaimer

$17.39

$0.36

(2.11%)

Day's range
$17.02
Day's range
$17.55
50-day range
$12.84
Day's range
$18.34
  • Country: US
  • ISIN: US6951271005
52 wk range
$11.16
Day's range
$35.95


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 1.04
  • Piotroski Score 6.00
  • Grade Sector Perform
  • Symbol (PCRX)
  • Company Pacira BioSciences, Inc.
  • Price $17.39
  • Changes Percentage (2.11%)
  • Change $0.36
  • Day Low $17.02
  • Day High $17.55
  • Year High $35.95

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 02/27/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $35.00
  • High Stock Price Target $63.00
  • Low Stock Price Target $8.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $1.51
  • Trailing P/E Ratio 18.92
  • Forward P/E Ratio 18.92
  • P/E Growth 18.92
  • Net Income $41.96 M

Income Statement

Quarterly

Annual

Latest News of PCRX

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Pacira BioSciences, Inc. Frequently Asked Questions

  • What were the earnings of PCRX in the last quarter?

    In the last quarter Pacira BioSciences, Inc. earnings were on Wednesday, November, 6th. The Pacira BioSciences, Inc. maker reported $0.79 EPS for the quarter, beating analysts' consensus estimates of $0.72 by $0.07.

  • What is the Pacira BioSciences, Inc. stock price today?

    Today's price of Pacira BioSciences, Inc. is $17.39 — it has increased by +2.11% in the past 24 hours. Watch Pacira BioSciences, Inc. stock price performance more closely on the chart.

  • Does Pacira BioSciences, Inc. release reports?

    Yes, you can track Pacira BioSciences, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Pacira BioSciences, Inc. stock forecast?

    Watch the Pacira BioSciences, Inc. chart and read a more detailed Pacira BioSciences, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Pacira BioSciences, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Pacira BioSciences, Inc. stock ticker.

  • How to buy Pacira BioSciences, Inc. stocks?

    Like other stocks, PCRX shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Pacira BioSciences, Inc.'s EBITDA?

    Pacira BioSciences, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Pacira BioSciences, Inc.’s financial statements.

  • What is the Pacira BioSciences, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0.0621575814, which equates to approximately 6.22%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Pacira BioSciences, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Pacira BioSciences, Inc.'s financials relevant news, and technical analysis. Pacira BioSciences, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Pacira BioSciences, Inc. stock currently indicates a “sell” signal. For more insights, review Pacira BioSciences, Inc.’s technical analysis.

  • A revenue figure for Pacira BioSciences, Inc. for its last quarter?

    Pacira BioSciences, Inc. published it's last quarterly revenues at $168.57 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.